Stephens Investment Management Group LLC Acquires 58,156 Shares of Ryan Specialty Holdings Inc. $RYAN

Stephens Investment Management Group LLC grew its stake in Ryan Specialty Holdings Inc. (NYSE:RYANFree Report) by 4.5% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,362,484 shares of the company’s stock after purchasing an additional 58,156 shares during the quarter. Stephens Investment Management Group LLC owned about 0.52% of Ryan Specialty worth $76,790,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Montrusco Bolton Investments Inc. acquired a new position in Ryan Specialty in the second quarter valued at about $213,852,000. Blair William & Co. IL increased its stake in shares of Ryan Specialty by 1.1% in the 2nd quarter. Blair William & Co. IL now owns 2,814,195 shares of the company’s stock valued at $191,337,000 after acquiring an additional 29,279 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Ryan Specialty by 3.9% in the 2nd quarter. Geode Capital Management LLC now owns 2,018,275 shares of the company’s stock valued at $137,244,000 after acquiring an additional 75,598 shares during the last quarter. Invesco Ltd. raised its position in shares of Ryan Specialty by 17.3% in the 2nd quarter. Invesco Ltd. now owns 1,865,325 shares of the company’s stock valued at $126,823,000 after acquiring an additional 274,463 shares during the period. Finally, Viking Global Investors LP boosted its stake in Ryan Specialty by 47.8% during the 2nd quarter. Viking Global Investors LP now owns 1,412,767 shares of the company’s stock worth $96,054,000 after acquiring an additional 456,878 shares during the last quarter. 84.82% of the stock is owned by institutional investors and hedge funds.

Ryan Specialty Trading Up 1.5%

Shares of NYSE:RYAN opened at $51.50 on Friday. The firm has a market cap of $13.59 billion, a price-to-earnings ratio of 111.96, a PEG ratio of 1.23 and a beta of 0.63. Ryan Specialty Holdings Inc. has a 12 month low of $49.88 and a 12 month high of $77.16. The company’s fifty day simple moving average is $54.08 and its 200 day simple moving average is $56.58. The company has a quick ratio of 1.00, a current ratio of 1.00 and a debt-to-equity ratio of 2.72.

Ryan Specialty (NYSE:RYANGet Free Report) last released its earnings results on Thursday, October 30th. The company reported $0.47 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.47. Ryan Specialty had a return on equity of 47.93% and a net margin of 7.61%.The firm had revenue of $754.58 million during the quarter, compared to analysts’ expectations of $742.35 million. During the same quarter in the prior year, the company earned $0.41 EPS. The company’s revenue was up 24.8% on a year-over-year basis. As a group, research analysts forecast that Ryan Specialty Holdings Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, November 25th. Investors of record on Tuesday, November 11th were issued a dividend of $0.12 per share. The ex-dividend date was Monday, November 10th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.9%. Ryan Specialty’s dividend payout ratio (DPR) is presently 104.35%.

Analyst Upgrades and Downgrades

Several brokerages have commented on RYAN. Mizuho set a $60.00 target price on shares of Ryan Specialty in a research note on Wednesday. Wells Fargo & Company boosted their price target on shares of Ryan Specialty from $61.00 to $63.00 and gave the company an “overweight” rating in a report on Tuesday. UBS Group lowered their price objective on shares of Ryan Specialty from $80.00 to $75.00 and set a “buy” rating for the company in a research report on Wednesday, October 8th. JPMorgan Chase & Co. reduced their target price on Ryan Specialty from $63.00 to $56.00 and set an “underweight” rating on the stock in a report on Wednesday, January 7th. Finally, TD Cowen decreased their target price on Ryan Specialty from $89.00 to $76.00 and set a “buy” rating for the company in a research note on Wednesday, November 26th. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $64.19.

View Our Latest Research Report on RYAN

Insider Transactions at Ryan Specialty

In other Ryan Specialty news, CEO Timothy William Turner sold 129,570 shares of the business’s stock in a transaction that occurred on Friday, December 12th. The stock was sold at an average price of $53.61, for a total value of $6,946,247.70. Following the sale, the chief executive officer owned 12,553 shares in the company, valued at approximately $672,966.33. The trade was a 91.17% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 52.21% of the company’s stock.

About Ryan Specialty

(Free Report)

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.

Featured Stories

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.